Greenlandic patients with colorectal cancer: symptomatology, primary investigations and differences in diagnostic intervals between Nuuk and the rest of the country

نویسندگان

  • Johan Tolstrup
  • Rasmus Chemnitz Madsen
  • Maria Vandborg Sneftrup
  • Birgit Niclasen
چکیده

BACKGROUND Colorectal cancer (CRC) is a potentially fatal disease, and expedited referral and treatment is needed to ensure early detection. OBJECTIVE We aimed to assess the symptomatology of Greenlandic patients with CRC and the primary investigations initiated before referral to Dronning Ingrids Hospital in Nuuk for further diagnostic workup. Primary care interval (first consultation until referral), hospital interval (referral until diagnosis) and diagnostic interval (first consultation until diagnosis) were calculated and compared between patients living in Nuuk and in other places in Greenland ("the Coast"). DESIGN This was a retrospective, register-based study of all patients in Greenland diagnosed with CRC from 2008 through 2011. Medical history was obtained and investigated by reviewing the primary care charts. RESULTS In total 113 patients were identified from the Greenlandic cancer database or pathology reports. About 80% of the patients were asked about blood in the stools and changes of bowel habits, and the majority responded positively to this. Abdominal examination was performed for 78%, 65% had a rectal examination performed, 22% a proctoscopy performed and 51% a haemoglobin level measured. The median primary care interval was 4 days in Nuuk vs. 55 days for patients from "the Coast" (p=0.01); the median diagnostic interval was 55 days in Nuuk vs. 95 days for patients from "the Coast" (p=0.04). Median hospital interval was similar for both groups (23 days vs 24 days; p=0.86). Women had a median primary care interval of 70 days vs. 15 days for men (p=0.06). CONCLUSIONS Patients with CRC presented classic symptomatology of CRC. Primary care interval and diagnostic interval were significantly longer for patients from "the Coast" compared with Nuuk. Women tended to have longer primary care interval. A more standardised examination should be implemented and a national CRC screening programme should be considered to reduce the difference in diagnostic interval and ensure timely referral.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluation of the Relationship between Peroxisome Proliferator Receptors (PPARα, PPARγ, and PPARδ) Expression and Carcinoembryonic Antigen (CEA) in Patients with Colorectal Cancer

Introduction: Studies have shown that an increase in carcinoembryonic antigen (CEA) is associated with the progression of colorectal cancer and is considered a sensitive diagnostic factor for CRC. Moreover, the role of peroxisome proliferators (PPARs) has recently been considered in colorectal cancer. This study aimed to investigate the relationship between the expression level of PPARs and CEA...

متن کامل

Does ethnicity affect survival following colorectal cancer? A prospective, cohort study using Iranian cancer registry

  Background:The present study compared the differences between survivals of patients with colorectal cancer according to their ethnicity adjusted for other predictors of survival.   Methods: In this prospective cohort study patients were followed up from definite diagnosis of colorectal cancer to death. Totally, 2431 person-year follow-ups were undertaken for 1127 colorectal cancer patients on...

متن کامل

Serum Levels of Zinc, Copper, Selenium and Glutathione Peroxidase in Different Groups of Colorectal Cancer Patients

Background: Colorectal cancer (CRC) is considered the fourth type of cancer that causes death in the world. Changes in levels of Zinc (Zn), Copper (Cu), and Selenium (Se) as well as low glutathione peroxidase (GPx) activity can lead to CRC and this study was aimed to evaluate their possible use as diagnostic markers. Methods: CRC patients (n=90) were divided into three groups; newly diagnosed,...

متن کامل

ارزیابی فراوانی جهش‌های ژن KRAS در بیماران ایرانی مبتلا به سرطان کولورکتال

Background: Kirsten rat sarcoma (KRAS) gene is a target of genetic alterations which are diagnostic and prognostic biomarkers in patients with metastatic colorectal cancer who are treated with monoclonal anti-EGFR antibodies such as cetuximab and panitumumab. KRAS mutations are seen in 35-42% of patients with colorectal cancer. The high frequency of these mutations in colorectal cancer represen...

متن کامل

تحلیل بقای بیماران سرطان کولورکتال و عوامل پیش‌آگهی دهنده با استفاده از مدل رگرسیون کاکس

 Background: Colorectal cancer is the third current cancer in the world and the forth cause of death in cancers. Certain factors such as environmental, genetic and life style are related with this cancer. The objective of this study is to find the survival of Iranian patients with colorectal cancer and also to find its prognostic factors. Methods: In this survival study, the data was co...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 76  شماره 

صفحات  -

تاریخ انتشار 2017